Biogend Therapeutics (Twse 6733)

BioGend is a company based in Taipei, Taiwan, that specializes in orthopedic and regenerative medicine products. One of our main innovations is RevoCart, a technology that can harvest, process, and implant autologous cartilage cells in a single surgery. Another breakthrough is SoufCut, a technology that can slice soft tissues that are hard to handle and obtain valuable SVF to fill under the skin. These are our two core technologies. BioGend not only has its own ISO7 facility to produce its own products, but also offers OEM services to external partners, delivering high-quality design and manufacturing to the whole world.